Comment on: "Animal model assessment of a new design for a coated mitomycin-eluting biodegradable ureteral stent for intracavitary instillation as an adjuvant therapy in upper urothelial carcinoma"

Minerva Urol Nephrol. 2023 Jun;75(3):401-403. doi: 10.23736/S2724-6051.23.05354-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Carcinoma, Transitional Cell*
  • Combined Modality Therapy
  • Mitomycin
  • Urinary Bladder Neoplasms*

Substances

  • Mitomycin